Global Chemotherapy Induced Anemia Market Analysis-2030
The Global Chemotherapy Induced Anaemia Market Size is expected to reach USD 3.99 billion by 2030, at a CAGR of 7.2% during the forecast period 2021 to 2030. Anaemia is a common complication of myelosuppressive chemotherapy, and the development of chemotherapy-induced anaemia is more common in patients with hematologic malignant tumours. Anaemia is caused due to a decrease in the count of the total number of red blood cells or haemoglobin in the blood.